Karyopharm announces presentations in endometrial cancer and myelofibrosis at the 2024 american society of clinical oncology annual meeting

Invited to present updated endometrial cancer data during special session "asco plenary series: rapid abstract updates" newton, mass. , april 24, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts detailing new selinexor data have been selected for presentation at the 2024 american society of clinical oncology annual meeting (2024 asco annual meeting) being held may 31 - june 4 in chicago, il.
KPTI Ratings Summary
KPTI Quant Ranking